Best Practice Sharing in Head and Neck Cancer Patient Management during COVID-19
Significant shifts have occurred in the management of head and neck cancer patients. Due to the COVID-19 pandemic, dramatic changes have occurred in clinical setup, management of AGPs non AGPs, dysphagia management and instrumental assessments involved in this patient group. As a result, new best practices have emerged and evolved. As things gradually start to return to a new normal, this live panel discussion will focus on best practice sharing and discussing the practicalities of returning to a ‘normal’ clinical setup. This includes considerations for the management of the anticipated post pandemic surge in head and neck cancer cases and hybrid virtual and in-person clinical setups.
International panel:
Dr J. Alexander Sistiaga Suárez, MD, FEBEORL-HNS, GOLF IFHNOS
Head and Neck Oncology Unit, ENT Department, Hospital Universitario Donostia, Spain
Prof Dr Vincent Vander Poorten, MD, PhD, MSc
Professor and Clinical Head of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Belgium
Section Head, Department of Oncology, section Head and Neck Oncology, KU Leuven, Belgium
Secretary General MSGS
Dr Justin Roe, BA(Hons), Dip THP, PG Dip, MSc, PhD
Consultant Speech and Language Therapist. Joint Head of Speech and Language Department, Royal Marsden Hospital, London, UK and Clinical Service Lead, National Centre for Airway Reconstruction/Ear, Nose and Throat Service at Imperial College Health Care NHS Trust, United Kingdom
Dr Francesco Missale, MD
Surgical Oncologist, IRCCS Ospedale Policlinico San Martino, Genoa, Italy and PhD student at the Department of Molecular and Translational Medicine at the University of Brescia, Italy
Reference mentioned during the discussion:
Safe management of laryngectomized patients during the COVID-19 pandemic
Share
Save to my content